Master Pharm, a contractual manufacturer of dietary supplements, is looking for an industry investor. The company announced that on Thursday it signed a due diligence agreement with a potential investor.
In a press release, the company also said that it has not made any strategic decision at the moment. There is also no certainty that the acquisition will be finalized in the future.
A few days earlier, Master Pharm announced that it had begun a review of strategic options that would support the further development of the company’s business. In addition to attracting an industry investor, the company is also considering other options.
Master Pharm specializes in contract manufacturing of dietary supplements. It also produces supplements under its own brand name. In the first three quarters of 2018, the company’s revenue amounted to PLN 52 million, compared to PLN 41 million in the previous year. From this amount, PLN 42 million came from contract production and nearly PLN 10 million from the sale of own products. The increase in revenues was mainly due to an increase in the portfolio of orders among new large customers and an increase in orders from existing customers.